Targeting IL-6 signalling has also been shown to suppress survival of glioma stem cells isolated from human glioblastoma xenografts (D456MG, D54MG) or from fresh human surgical specimens and tumour growth [66]. The gene discussed is IL6; the disease is glioblastoma.